Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Cost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares Issued
Ratios

SOPHiA GENETICS (SOPH) Cost of Revenue (2020 - 2025)

SOPHiA GENETICS's Cost of Revenue history spans 6 years, with the latest figure at $7.0 million for Q4 2025.

  • On a quarterly basis, Cost of Revenue rose 24.58% to $7.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $25.2 million, a 18.64% increase, with the full-year FY2025 number at $25.2 million, up 18.64% from a year prior.
  • Cost of Revenue hit $7.0 million in Q4 2025 for SOPHiA GENETICS, up from $6.6 million in the prior quarter.
  • Over the last five years, Cost of Revenue for SOPH hit a ceiling of $7.0 million in Q4 2025 and a floor of $3.4 million in Q1 2021.
  • Historically, Cost of Revenue has averaged $4.9 million across 5 years, with a median of $5.0 million in 2023.
  • The widest YoY moves for Cost of Revenue: up 131406.38% in 2021, down 99.8% in 2021.
  • Tracing SOPH's Cost of Revenue over 5 years: stood at $4.1 million in 2021, then fell by 8.62% to $3.8 million in 2022, then skyrocketed by 37.22% to $5.1 million in 2023, then increased by 9.34% to $5.6 million in 2024, then rose by 24.58% to $7.0 million in 2025.
  • Business Quant data shows Cost of Revenue for SOPH at $7.0 million in Q4 2025, $6.6 million in Q3 2025, and $6.1 million in Q2 2025.